Predicting overall survival in anaplastic thyroid cancer using machine learning approaches.

IF 1.9 3区 医学 Q2 OTORHINOLARYNGOLOGY European Archives of Oto-Rhino-Laryngology Pub Date : 2024-09-21 DOI:10.1007/s00405-024-08986-2
Arnavaz Hajizadeh Barfejani, Mohammadreza Rostami, Mohammad Rahimi, Hossein Sabori Far, Shahab Gholizadeh, Morteza Behjat, Aidin Tarokhian
{"title":"Predicting overall survival in anaplastic thyroid cancer using machine learning approaches.","authors":"Arnavaz Hajizadeh Barfejani, Mohammadreza Rostami, Mohammad Rahimi, Hossein Sabori Far, Shahab Gholizadeh, Morteza Behjat, Aidin Tarokhian","doi":"10.1007/s00405-024-08986-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Anaplastic thyroid carcinoma (ATC) is a highly aggressive and lethal thyroid cancer subtype with a poor prognosis. Recent advancements in machine learning (ML) have the potential to improve survival predictions. This study aimed to develop and validate ML models using the SEER database to predict 3-month, 6-month, and 12-month (overall survival) OS in ATC patients.</p><p><strong>Methods: </strong>Clinical and demographic data for patients with ATC from the SEER database (2004-2015) were utilized. Five ML algorithms-AdaBoost, support vector machines, gradient boosting classifiers, random forests, and naive Bayes-were evaluated. The data were split into training and testing sets (7:3 ratio), and the models were tuned using fivefold cross-validation. Model performance was assessed using the concordance index (C-index) and Brier score, with 95% confidence intervals reported.</p><p><strong>Results: </strong>The gradient boosting model achieved the greatest performance for 3-month survival (C-index: 0.8197, 95% CI 0.7682-0.8689; Brier score: 0.1802), and the AdaBoost model achieved the greatest performance in 6-month survival (C-index: 0.8473, 95% CI 0.7979-0.8933; Brier score: 0.1775). The SVC model showed superior performance for 12-month survival (C-index: 0.8347, 95% CI 0.7866-0.8816; Brier score: 0.1476). Using SHAP with a gradient boosting model, the top five features affecting 6-month OS were identified: surgery, the presence of stage IVC, radiation, chemotherapy, and tumor size. Treatment improved survival, while higher stages reduced survival, with smaller tumors generally linked to better outcomes.</p><p><strong>Conclusion: </strong>ML algorithms can accurately predict short-term survival in ATC patients. These models can potentially guide clinical decision-making and individualized treatment strategies.</p>","PeriodicalId":11952,"journal":{"name":"European Archives of Oto-Rhino-Laryngology","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Archives of Oto-Rhino-Laryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00405-024-08986-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Anaplastic thyroid carcinoma (ATC) is a highly aggressive and lethal thyroid cancer subtype with a poor prognosis. Recent advancements in machine learning (ML) have the potential to improve survival predictions. This study aimed to develop and validate ML models using the SEER database to predict 3-month, 6-month, and 12-month (overall survival) OS in ATC patients.

Methods: Clinical and demographic data for patients with ATC from the SEER database (2004-2015) were utilized. Five ML algorithms-AdaBoost, support vector machines, gradient boosting classifiers, random forests, and naive Bayes-were evaluated. The data were split into training and testing sets (7:3 ratio), and the models were tuned using fivefold cross-validation. Model performance was assessed using the concordance index (C-index) and Brier score, with 95% confidence intervals reported.

Results: The gradient boosting model achieved the greatest performance for 3-month survival (C-index: 0.8197, 95% CI 0.7682-0.8689; Brier score: 0.1802), and the AdaBoost model achieved the greatest performance in 6-month survival (C-index: 0.8473, 95% CI 0.7979-0.8933; Brier score: 0.1775). The SVC model showed superior performance for 12-month survival (C-index: 0.8347, 95% CI 0.7866-0.8816; Brier score: 0.1476). Using SHAP with a gradient boosting model, the top five features affecting 6-month OS were identified: surgery, the presence of stage IVC, radiation, chemotherapy, and tumor size. Treatment improved survival, while higher stages reduced survival, with smaller tumors generally linked to better outcomes.

Conclusion: ML algorithms can accurately predict short-term survival in ATC patients. These models can potentially guide clinical decision-making and individualized treatment strategies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用机器学习方法预测无性甲状腺癌的总生存期
目的:甲状腺无节细胞癌(ATC)是一种侵袭性强、致死率高、预后不良的甲状腺癌亚型。机器学习(ML)的最新进展有可能改善生存预测。本研究旨在利用 SEER 数据库开发和验证 ML 模型,以预测 ATC 患者 3 个月、6 个月和 12 个月(总生存期)的 OS:研究利用了 SEER 数据库(2004-2015 年)中 ATC 患者的临床和人口统计学数据。评估了五种 ML 算法--AdaBoost、支持向量机、梯度提升分类器、随机森林和天真贝叶斯。数据被分成训练集和测试集(比例为 7:3),并使用五倍交叉验证对模型进行调整。使用一致性指数(C-index)和布赖尔评分评估模型性能,并报告 95% 的置信区间:梯度提升模型在 3 个月存活率方面表现最佳(C-index:0.8197,95% CI 0.7682-0.8689; Brier score:0.1802),AdaBoost 模型在 6 个月存活率方面表现最佳(C-index:0.8473,95% CI 0.7979-0.8933; Brier score:0.1775)。SVC 模型在 12 个月生存率方面表现更优(C 指数:0.8347,95% CI 0.7866-0.8816; Brier 评分:0.1476)。利用 SHAP 和梯度提升模型,确定了影响 6 个月生存率的五大特征:手术、IVC 期、放疗、化疗和肿瘤大小。治疗提高了生存率,而较高的分期则降低了生存率,较小的肿瘤通常与较好的预后有关:结论:ML 算法可以准确预测 ATC 患者的短期生存率。这些模型可为临床决策和个体化治疗策略提供潜在指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.30
自引率
7.70%
发文量
537
审稿时长
2-4 weeks
期刊介绍: Official Journal of European Union of Medical Specialists – ORL Section and Board Official Journal of Confederation of European Oto-Rhino-Laryngology Head and Neck Surgery "European Archives of Oto-Rhino-Laryngology" publishes original clinical reports and clinically relevant experimental studies, as well as short communications presenting new results of special interest. With peer review by a respected international editorial board and prompt English-language publication, the journal provides rapid dissemination of information by authors from around the world. This particular feature makes it the journal of choice for readers who want to be informed about the continuing state of the art concerning basic sciences and the diagnosis and management of diseases of the head and neck on an international level. European Archives of Oto-Rhino-Laryngology was founded in 1864 as "Archiv für Ohrenheilkunde" by A. von Tröltsch, A. Politzer and H. Schwartze.
期刊最新文献
Correction: Long-term voice outcomes of medialization thyroplasty with adjustable implant for unilateral vocal fold paralysis. Correction: Management of Petrous Bone Cholesteatoma: The Gruppo Otologico Experience. Success and safety of endoscopic versus microscopic resection of temporal bone paraganglioma: a meta-analysis. Rhinitis medicomentosa and substance addiction. Heated humidified high-flow nasal cannula: a new conservative approach for neonatal nasal stenosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1